Virtue Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
+501
| New | +$263K | 0.05% | 218 |
|
|
2021
Q4 | – | Sell |
-360
| Closed | -$218K | – | 434 |
|
|
2021
Q3 | $218K | Sell |
360
-65
| -15% | -$39.4K | 0.04% | 355 |
|
|
2021
Q2 | $237K | Hold |
425
| – | – | 0.05% | 288 |
|
|
2021
Q1 | $201K | Buy |
+425
| New | +$201K | 0.05% | 272 |
|
|
2020
Q4 | – | Sell |
-2,597
| Closed | -$1.45M | – | 269 |
|
|
2020
Q3 | $1.45M | Sell |
2,597
-761
| -23% | -$426K | 0.36% | 79 |
|
|
2020
Q2 | $2.09M | Buy |
+3,358
| New | +$2.09M | 0.48% | 61 |
|